November 9, 2013Diabetes Obesity and Metabolism162 citations

Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta‐analysis

OPOlivia J Phung DSDiana M Sobieraj SESamuel S. Engel

Key Points

Key points are not available for this paper at this time.

Abstract

These results suggest a potential benefit of initial combination therapy on glycaemic outcomes in diabetes compared to metformin monotherapy across a wide range of baseline A1c levels. Further research should explore if early combination treatment may also affect longer term health outcomes in diabetes.

KI fragen

Bookmark

View Full Paper

Cite This Study

Phung et al. (Sat,) studied this question.

synapsesocial.com/papers/69d73b1535079b684748f664 https://doi.org/https://doi.org/10.1111/dom.12233

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well‐controlled Type 2 diabetes2006 · 38 citations
2Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment‐naive patients with type 2 diabetes mellitus2009 · 174 citations
3Meta-analysis in clinical trials1986 · 39,791 citations
4Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus2001 · 177 citations
5Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care2007 · 198 citations

KI fragen

Bookmark

View Full Paper